Scandion Oncology

Developer of drugs that specifically target chemotherapy resistance mechanisms

placeCopenhagen, Capital Region Of Denmark, Denmark calendar_todayFounded 2016 groups3 employees language scandiononcology.com

Registered entities

Investor mix

4 investors on record.

Investor typeCountShare
Accelerator & incubator125%
Other / undisclosed375%
Coming soon